Newsroom
Sorted by: Latest
-
FPT Software Positioned as a Leader in IDC MarketScape Report for AI-Enabled Front Office Conversational AI Software in Asia-Pacific
HANOI, Vietnam--(BUSINESS WIRE)--FPT Software, the global IT services subsidiary of FPT Corporation (FPT), is positioned as a Leader in the IDC MarketScape: Asia/Pacific AI-Enabled Front Office Conversational AI Software 2025 Vendor Assessment (doc # AP52998625e, November 2025). The IDC MarketScape evaluates 17 vendors in the Asia/Pacific region based on two major criteria: capability and strategy. Key factors include functionality, innovation in conversational AI, long-term vision, infrastruct...
-
Nattakorn Wattanaumphaipong Joins Great American Insurance Company’s Singapore Branch
SINGAPORE & CINCINNATI--(BUSINESS WIRE)--Great American is pleased to announce the hiring of Nattakorn Wattanaumphaipong as Senior Director, Technical Underwriting for the Singapore Branch....
-
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities
SINGAPORE--(BUSINESS WIRE)--Ant International is collaborating with Google on the launch of its Universal Commerce Protocol (UCP), a new open standard for agentic commerce....
-
CDB Aviation Signs New Sustainability Linked Unsecured Term Loan for $710 Million
DUBLIN--(BUSINESS WIRE)--CDB Aviation executed a new Sustainability Linked Loan transaction anchored with a five-year $710 million unsecured term loan facility....
-
UPPF Opens Shanghai Technical Center to Accelerate Product Support, Quality Management, and Installer Training
SHANGHAI--(BUSINESS WIRE)--UPPF announced the grand opening of its Technical Center in Shanghai, a 3,000 sq ft facility designed to deliver faster, more comprehensive product support, strengthen quality management, and expand installation training for dealers and partners across Asia and beyond. The new center aligns with UPPF’s commitment to practical innovation and customer success, captured in the event theme: “Your Growth, Our Mission.” “This Technical Center is built to help our customers...
-
SNCY Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Sun Country Airlines Holdings, Inc. is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY) to Allegiant Travel Company for 0.1557 shares of Allegiant common stock and $4.10 in cash for each Sun Country share is fair to Sun Country shareholders. Halper Sadeh encourages Sun Country shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@...
-
ALGT Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Allegiant Travel Company is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Allegiant Travel Company (NASDAQ: ALGT) and Sun Country Airlines is fair to Allegiant shareholders. Upon completion of the proposed transaction, Allegiant shareholders will own approximately 67% of the combined company. Halper Sadeh encourages Allegiant shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763...
-
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs...
-
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new five-year strategy, “Alnylam 2030,” focused on scaling the Company’s operations through achieving leadership in ATTR amyloidosis, driving long-term growth through sustainable innovation, and delivering exceptional financial results with discipline and agility. Alnylam also today reported preliminary* fourth quarter and full year 2025 global net product...
-
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the quarter and full year ended December 31, 2025. Fourth quarter 2025 preliminary unaudited financial results For the three-month period ended December 31, 2025, as compared to the same period of 2024: Total revenue of approximately $280 million, an increase of 39% Reported approximately 79,000 oncology tests, an increase of 38% Report...